| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.089 | 0.008 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.091 | 0.008 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.096 | 0.009 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.086 | 0.009 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.009 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.009 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.009 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.36 | 0.01 |